Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China

Authors

  • Gui-Ming Zhang,

    1. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
    2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    Search for more papers by this author
  • Yao Zhu,

    1. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
    2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    Search for more papers by this author
  • Lei Luo,

    1. Department of Urology, The Affiliated Hospital of Medical College, Qingdao University, Qingdao, China
    Search for more papers by this author
  • Hai-Liang Zhang,

    1. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
    2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    Search for more papers by this author
  • Cheng-Yuan Gu,

    1. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
    2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    Search for more papers by this author
  • Li-Jiang Sun,

    Corresponding author
    1. Department of Urology, The Affiliated Hospital of Medical College, Qingdao University, Qingdao, China
    • Correspondence: Li-Jiang Sun, Department of Urology, The Affiliated Hospital of Medical College, Qingdao University, No. 16, Jiangsu Rd, Qingdao, Shandong 266003, China.

      e-mail: slijiang999@126.com

      Ding-Wei Ye, Department of Urology, Fudan University Shanghai Cancer Center, No. 270, Dongan Rd, Shanghai 200023, China.

      e-mail: dwyeli@163.com

    Search for more papers by this author
  • Ding-Wei Ye

    Corresponding author
    1. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
    2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    • Correspondence: Li-Jiang Sun, Department of Urology, The Affiliated Hospital of Medical College, Qingdao University, No. 16, Jiangsu Rd, Qingdao, Shandong 266003, China.

      e-mail: slijiang999@126.com

      Ding-Wei Ye, Department of Urology, Fudan University Shanghai Cancer Center, No. 270, Dongan Rd, Shanghai 200023, China.

      e-mail: dwyeli@163.com

    Search for more papers by this author

  • G.M.Z. and Y.Z contributed equally to this work

Abstract

Objective

To examine the prevalence of dyslipidaemia in patients with renal cell carcinoma (RCC) in a Chinese population.

Patients and Methods

In all, 550 histologically confirmed RCC cases and 570 controls, matched for age and sex were included. Total cholesterol, triglyceride, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) were assessed before treatment using standard techniques. The lipid profiles were defined as ‘normal’, ‘borderline high’, ‘high’ and ‘low’ according to Chinese Guidelines on Adult Dyslipidaemia. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression in both unadjusted and adjusted models.

Results

Abnormal LDL elevation was common in RCC cases compared with controls (P < 0.001). Results for total cholesterol, triglyceride and HDL levels between groups were insignificant. The OR for RCC for high levels of LDL (≥160 mg/dL) compared with those with a normal LDL profile was 4.675 (95% CI 1.900–11.500). After adjustment for age, gender, body mass index, smoking status, hypertension, diabetes, total cholesterol and triglyceride, the coexistence of high levels of LDL and RCC was large and statistically significant (OR 8.955, 95% CI 3.371–23.786). There was a significant coexistence of RCC for participants with high LDL levels when subgroups of cases with clear cell subtypes and advanced T stages were compared with controls.

Conclusion

Abnormal LDL elevation was prevalent in Chinese patients with RCC. The results remain to be evaluated in prospective cohorts.

Ancillary